Patch-free Occlusion Therapy
ConditionAmblyopia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-12
SponsorRetina Foundation of the Southwest
About this trial
The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.
Eligibility criteria
Qualifiers
3-12 years
male and female
strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)
interocular visual acuity difference ≥0.3 logMAR
Disqualifiers
Prematurity ≥8 wk
coexisting ocular or systemic disease
developmental delay
myopia > -3.00D
Trial design
Treatments tested in this trial
- Patch-free occlusion therapy
- Adhesive patch
Treatment groups
68 Participants
are divided into 2 treatment groupsSponsors and collaborators
Retina Foundation of the Southwest
Lead sponsor
National Eye Institute (NEI)
Collaborator
Source ClinicalTrials.gov